Differentiating the effects of centrally acting drugs on arousal and memory: an event-related potential study of scopolamine, lorazepam and diphenhydramine
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
The degree to which apparent amnesic effects of various centrally acting drugs are secondary to their effects on arousal remains a contentious issue. The present study uses two methods to dissociate memory and arousal effects of the cholinergic antagonist, scopolamine (SP), and the GABA-A/benzodiazepine receptor agonist, lorazepam (LZ). First, it compared their effects to those of an antihistamine, diphenhydramine (DPh), to provide an active control for arousal reduction. Second, it used the same measure--event-related potentials (ERPs)--as as a parallel index of both the arousal and cognitive effects of the drugs. Fifty participants were allocated to one of five parallel treatment groups (0.6 mg SP; 2 mg LZ; 25, 50 mg DPh; placebo). ERPs were recorded during a continuous word recognition task as well as during an "oddball" task. SP, LZ and 50 mg DPh produced a similar profile of effects on certain indices of arousal and on early components of ERPs. However, SP and LZ (but not DPh) produced marked impairments of episodic memory, and this pattern was similar to that on later components of ERPs. Memory impairments by SP and LZ were highly significant on retention in the continuous recognition task and further, no drug effects were found on response bias. Subsequent free recall was similarly very impaired by SP and LOR but not by the antihistamine. We conclude that benzodiazepines and anticholinergic drugs both reduce arousal and induce amnesia, but these effects are not interdependent. Our findings provide strong evidence for a dissociation between the effects on episodic memory and on arousal of these centrally acting compounds.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Many medications, such as benzodiazepines, opioids, and anticholinergics, can cause side effects at the central nervous system, including sedation and cognitive impairment, which may exacerbate sarcopenia and compromise coordination and dual-task performance.”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [582]
In the citing paper
“These cognitive deficits can lead to diminished physical capabilities, impaired balance, and an increased risk of falls, potentially deterring patients from participating in progressive balance exercises [[581], [582], [583], [584]].”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [582]
In the citing paper
“Many medications, such as benzodiazepines, opioids, and anticholinergics, can cause side effects at the central nervous system, including sedation and cognitive impairment, which may exacerbate sarcopenia and compromise coordination and dual-task performance. These cognitive deficits can lead to diminished physical capabilities, impaired balance, and an increased risk of falls, potentially deter”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [582]
Citations
Cites
Concreteness, imagery, and meaningfulness values for 925 nouns.
Paivio, A., Yuille, J. C., & Madigan, S. A. (1968) · Journal of Experimental Psychology · doi:10.1037/h0025327 · Cited by 2,827
Priming and Human Memory Systems
Tulving, E., & Schacter, D. L. (1990) · Science · doi:10.1126/science.2296719 · Cited by 2,595 · cited 3×
“In the language of Tulving s (1985; Tulving and Schacter 1990) memory systems, both scopolamine (SP) and benzodiazepines (BDZs) produce marked anterograde impairments of episodic memory while leaving semantic, procedural and working memory relatively intact.”
BackgroundMethodInfluentialThe Pharmacological Basis of Therapeutics
Goodman, L., & Gilhan, A. (1941) · Anesthesiology · doi:10.1097/00000542-194105000-00013 · Cited by 2,146
Electrical Signs of Selective Attention in the Human Brain
Hillyard, S. A., Hink, R. F., Schwent, V. L., & Picton, T. W. (1973) · Science · doi:10.1126/science.182.4108.177 · Cited by 1,934 · cited 1×
“Reduced N1 amplitude is known to be associated with a reduction in arousal (Hillyard et al. 1973).”
BackgroundHow many memory systems are there?
Tulving, E. (1985) · American Psychologist · doi:10.1037/0003-066x.40.4.385 · Cited by 1,909
(1967) · Medical Entomology and Zoology · Cited by 1,115
Selective attention and evoked potentials inhumans — A critical review
Näätänen, R. (1975) · Biological Psychology · doi:10.1016/0301-0511(75)90038-1 · Cited by 339 · cited 2×
“The various components from then to about 250 m are believed to reßect speciÞc perceptual and cognitive processes and are inßuenced by attention, arousal and activation (Naatanen 1975).”
Benzodiazepines and Human Memory: A Review
(1990) · Anesthesiology · doi:10.1097/00000542-199005000-00024 · Cited by 298
Dissociation of Semantic Priming, Word and Non-Word Repetition Effects by Event-Related Potentials
Rugg, M. D. (1987) · The Quarterly Journal of Experimental Psychology Section A · doi:10.1080/02724988743000060 · Cited by 267 · cited 2×
“We would argue that ERPs o¤er a potentially important tool in the debate about sedation and memory, both because di¤erent ERP components are associated with arousal and memory (Rugg 1987; Rugg and Nagy 1989) and because essentially the same measure is used to assess both e¤ects.”
BackgroundSensitivity and responsivity measures for discrimination learning
Frey, P. W., & Colliver, J. A. (1973) · Learning and Motivation · doi:10.1016/0023-9690(73)90023-4 · Cited by 235 · cited 1×
“Recognition data were subjected to signal detection analyses (Frey and Colliver, 1973).”
Method
Cited by
A refined model of sleep and the time course of memory formation
Walker, M. P. (2005) · Behavioral and Brain Sciences · doi:10.1017/s0140525x05000026 · Cited by 468
Izquierdo, M., de Souto Barreto, P., Arai, H., Bischoff-Ferrari, H. A., Cadore, E. L., Cesari, M., Chen, L.-K., Coen, P. M., Courneya, K. S., Duque, G., et al. (2025) · The Journal of nutrition, health and aging · doi:10.1016/j.jnha.2024.100401 · Cited by 273
Functional MRI detection of pharmacologically induced memory impairment
Sperling, R., Greve, D., Dale, A., Killiany, R., Holmes, J., Rosas, H. D., Cocchiarella, A., Firth, P., Rosen, B., Lake, S., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012467899 · Cited by 208
Atri, A., Sherman, S., Norman, K. A., Kirchhoff, B. A., Nicolas, M. M., Greicius, M. D., Cramer, S. C., Breiter, H. C., Hasselmo, M. E., & Stern, C. E. (2004) · Behavioral Neuroscience · doi:10.1037/0735-7044.118.1.223 · Cited by 162
Drug targets for cognitive enhancement in neuropsychiatric disorders.
Wallace, T. L., Ballard, T. M., Pouzet, B., Riedel, W. J., & Wettstein, J. G. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.03.022 · Cited by 127
“…consistently shown, however, that H1 receptor antagonists have no effect on episodic memory in humans but do impair working memory, attention, speed of processing, psychomotor processes and subjective arousal (Curran et al., 1998; Turner et al., 2006; Van Ruitenbeek et al., 2009a,b, 2008, 2010b,c).”
Sedation and antihistamines: a review of inter-drug differences using proportional impairment ratios
Shamsi, Z., & Hindmarch, I. (2000) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/1099-1077(200010)15:1+<::aid-hup247>3.0.co;2-s · Cited by 117
Cognitive methods for assessing mental energy
Lieberman, H. R. (2007) · Nutritional Neuroscience · doi:10.1080/10284150701722273 · Cited by 117
“Benzodiazepines have potent and specific effects on memory, unlike some other hypnotics (Curran 1991; Curran et al. 1998).”
BackgroundUsing EEG to monitor anesthesia drug effects during surgery
Jameson, L. C., & Sloan, T. B. (2006) · Journal of Clinical Monitoring and Computing · doi:10.1007/s10877-006-9044-x · Cited by 130
Selective impairment in the recognition of anger induced by diazepam
Blair, J., & Curran, H. V. (1999) · Psychopharmacology · doi:10.1007/s002130051177 · Cited by 119
Self-citationKenemans, J. L., & Kähkönen, S. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.157 · Cited by 104
“One approach to this problem is to include an additional control condition with another sedating substance that however targets a different neurotransmitter system that is not implicated in memory function (see discussion of the Curran et al (1998) study in the section on P300).”
InfluentialAuditory Sensory Memory and the Cholinergic System: Implications for Alzheimer's Disease
Pekkonen, E., Hirvonen, J., Jääskeläinen, I. P., Kaakkola, S., & Huttunen, J. (2001) · NeuroImage · doi:10.1006/nimg.2001.0805 · Cited by 103
Pharmacological Modulation of Behavioral and Neuronal Correlates of Repetition Priming
Thiel, C. M., Henson, R. N. A., Morris, J. S., Friston, K. J., & Dolan, R. J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-17-06846.2001 · Cited by 97
“Although cholinergic modulation of learning, and corresponding neuronal activity, has been shown in many explicit learning paradigms (Caine et al., 1981; Frith et al., 1984; Nissen et al., 1987; Rusted and Warburton, 1988; Curran et al., 1991a; Furey et al., 2000), its effects on behavioral measures in implicit paradi…”
BackgroundA Neuroanatomical Construct for the Amnesic Effects of Propofol
Veselis, R. A., Reinsel, R. A., Feshchenko, V. A., & Dnistrian, A. M. (2002) · Anesthesiology · doi:10.1097/00000542-200208000-00008 · Cited by 74
What do phasic cholinergic signals do?
Sarter, M. F., Lustig, C., Berry, A. S., Gritton, H. J., Howe, W. M., & Parikh, V. (2016) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2016.02.008 · Cited by 81
Glass, J. R., Sproule, B. A., Herrmann, N., Streiner, D. L., & Busto, U. E. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000084033.22282.b6 · Cited by 90
Scopolamine but Not Lorazepam Modulates Face Repetition Priming A Psychopharmacological fMRI Study
Thiel, C. M., Henson, R. N., & Dolan, R. J. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00316-0 · Cited by 68
“Curran et al. (1991) investigated amnesic effects of scopolamine and lorazepam and included a control group that received an antihistamine with sedative but no memory impairing effects.”
BackgroundMethodResultInfluentialTheunissen, E. L., Vermeeren, A., Oers, A. C. M. V., Maris, I. V., & Ramaekers, J. G. (2004) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2004.01874.x · Cited by 63
Veselis, R. A., Reinsel, R. A., Feshchenko, V. A., & Johnson, R. (2004) · Anesthesiology · doi:10.1097/00000542-200410000-00006 · Cited by 70
“Different forms of memory impairment have been demonstrated previously, although the distinction is made with some difficulty.(4,18,19) If recognition or recall of previously presented material is only tested after a certain time after presentation of the material, much information regarding the effects of drug on mem…”
BackgroundCholinergic drugs affect novel object recognition in rats: Relation with hippocampal EEG?
Sambeth, A., Riedel, W. J., Smits, L. T., & Blokland, A. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.06.018 · Cited by 65
“Even though some evidence is in favor of a decrement in arousal in this experiment, other studies in which acetylcholine was manipulated using scopolamine have argued against this possibility (Curran et al., 1998; Molchan et al., 1992; Sloan et al., 1992).”
Thiel, C. M. (2003) · Neurobiology of Learning and Memory · doi:10.1016/s1074-7427(03)00076-5 · Cited by 64
Noradrenergic and cholinergic modulation of late ERP responses to deviant stimuli
Brown, S. B. R. E., van der Wee, N. J. A., van Noorden, M. S., Giltay, E. J., & Nieuwenhuis, S. (2015) · Psychophysiology · doi:10.1111/psyp.12544 · Cited by 57
“One study reported an amplitude reduction at Pz (Brandeis, Naylor, Halliday, Callaway, & Yano, 1992), and a final study reported an amplitude reduction by scopolamine and no interaction with electrode site (Fz, Cz, Pz; Curran et al., 1998).”
Rammsayer, T. H., Rodewald, S., & Groh, D. (2000) · Cognitive Brain Research · doi:10.1016/s0926-6410(99)00045-2 · Cited by 61
Triazolam-amphetamine interaction: dissociation of effects on memory versus arousal
Mintzer, M. Z., & Griffiths, R. R. (2003) · Journal of Psychopharmacology · doi:10.1177/0269881103017001689 · Cited by 46
Drugs and Human Memory (Part 2): Clinical, Theoretical, and Methodologic Issues
Ghoneim, M. M., & Warner, D. O. (2004) · Anesthesiology · doi:10.1097/00000542-200405000-00033 · Cited by 55
Samuels, E. R., Hou, R. H., Langley, R. W., Szabadi, E., & Bradshaw, C. M. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301363 · Cited by 46
“On the other hand, the benzodiazepines have been reported with some consistency to be able to suppress the amplitude of the N1/P2 component (Lader, 1977; Pooviboonsuk et al, 1996; Curran et al, 1998; Abduljawad et al, 2001).”
BackgroundLorazepam Strongly Prolongs Visual Information Processing
Giersch, A., & Herzog, M. H. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300429 · Cited by 45
“Subjects treated with benzodia- zepines have also been shown to need more time to distinguish between two consecutive events, that is, treated participants have lower fusion frequency (Danjou et al, 1992; Berlin et al, 1993; Maddock et al, 1993; Curran et al, 1993, 1998; MacNab et al, 1985).”
BackgroundCho, W., Maruff, P. T., Connell, J., Gargano, C., Calder, N. A., Doran, S. M., Fox‐Bosetti, S., Hassan, A., Renger, J. J., Herman, G. A., et al. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2344-y · Cited by 43
“However, antihistaminergic agents rarely induce impairments in human memory other than as measured with reaction time, which may be explained by sedative effects (e.g., Curran et al. 1998; Van Ruitenbeek et al. 2010).”
BackgroundLorazepam, sedation, and conscious recollection: a dose-response study with healthy volunteers
Huron, C., Giersch, A., & Danion, J. (2002) · International Clinical Psychopharmacology · doi:10.1097/00004850-200201000-00003 · Cited by 40
“Indeed some studies have concluded that the effects of benzodiazepines on episodic memory might be dissociated from their sedative effects (e.g. Coenen and van Luijtelaar, 1997; Curran et al., 1998) whereas others reported a correlation between the episodic memory impairment and sedation (e.”
BackgroundWeerts, A., Pattyn, N., Van de Heyning, P., & Wuyts, F. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881113516201 · Cited by 38
“, 1997) while others did not observe any effect (Acons et al., 2006; Bower et al., 2003; Curran et al., 1998; Hindmarch and Shamsi, 2001).”
BackgroundScopolamine induces impairments in the recognition of human facial expressions of anger and disgust
Kamboj, S. K., & Curran, H. V. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0332-4 · Cited by 41
“These doses of lorazepam and scopolamine were previously matched for amnestic and subjective effects (Curran et al. 1998).”
BackgroundSelf-citationSedation and memory: studies with a histamine H-1 receptor antagonist
Turner, C., Handford, A. D. F., & Nicholson, A. N. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106059804 · Cited by 43
Acute cognitive effects of donepezil in young, healthy volunteers
Zaninotto, A. L., Bueno, O. F. A., Pradella‐Hallinan, M., Tufik, S. B., Rusted, J. M., Stough, C. K. K., & Pompéia, S. (2009) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1044 · Cited by 43
“Differently, it is clear that explicit/declarative episodic memory (see Squire, 1986) is impaired by acute administration of anticholinergics in healthy adults (e.g., Broocks et al., 1998; Curran et al., 1998; Curran, 2000; Ellis et al., 2006).”
BackgroundWezenberg, E., Sabbe, B., Hulstijn, W., Ruigt, G. S. F., & Verkes, R. J. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106071550 · Cited by 39
Reneerkens, O. A. H., Sambeth, A., Ramaekers, J. G., Steinbusch, H. W. M., Blokland, A., & Prickaerts, J. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113477747 · Cited by 33
“This task assessed recognition memory and was used as an immediate recognition test (based on a task used by e.g. Curran et al., 1998; Van Strien et al., 2007).”
Methodde Brouwer, G., & Wolmarans, D. W. (2018) · Behavioural Processes · doi:10.1016/j.beproc.2018.04.011 · Cited by 40
Mintzer, M. Z., & Griffiths, R. R. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0726-y · Cited by 35
“Curran et al. (1998) and Veselis et al. (2001) both provided evidence that the sedative and amnestic effects of benzodiazepines are associated with different event-related potential components.”
BackgroundSambeth, A., Riedel, W. J., Klinkenberg, I., Kähkönen, S., & Blokland, A. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3822-9 · Cited by 35
Klinkenberg, I., Blokland, A., Riedel, W. J., & Sambeth, A. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2872-0 · Cited by 33
Scaife, J. C., Langley, R. W., Bradshaw, C. M., & Szabadi, E. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105053285 · Cited by 31
Cognitive domains affected by histamine H1-antagonism in humans: A literature review
van Ruitenbeek, P., Vermeeren, A., & Riedel, W. J. (2010) · Brain Research Reviews · doi:10.1016/j.brainresrev.2010.04.008 · Cited by 30
Neutral and emotional episodic memory: global impairment after lorazepam or scopolamine
Kamboj, S. K., & Curran, H. V. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0552-7 · Cited by 31
“Secondly, comparison studies have established equivalent doses for amnesic and sedative effects (e.g., Curran et al. 1998 ).”
BackgroundMethodResultInfluentialSelf-citationFornaro, M., Caiazza, C., Simone, G. D., Rossano, F., & de Bartolomeis, A. (2023) · Sleep Medicine · doi:10.1016/j.sleep.2023.11.033 · Cited by 30
Effects of Triazolam on Brain Activity During Episodic Memory Encoding: A PET Study
Mintzer, M. Z., Griffiths, R. R., Contoreggi, C., Kimes, A. S., London, E. D., & Ernst, M. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00280-9 · Cited by 27
“Furthermore, a study by Curran et al. (1998) in which event-related potentials were recorded in participants receiving lorazepam, scopolamine, or diphenhydramine, provided evidence for dissociation of the effects of lorazepam (and scopolamine) on memory and arousal.”
BackgroundWeber, L. A. E., Tomiello, S., Schöbi, D., Wellstein, K. V., Mueller, D. R., Iglesias, S., & Stephan, K. E. (2022) · eLife · doi:10.7554/elife.74835 · Cited by 29
“Studies using the muscarinic antagonist scopolamine have reported reductions of MMN amplitudes (Pekkonen et al., 2001), no effects on MMN (Pekkonen et al., 2005), and reduced P300 responses to targets in active oddball tasks (Meador et al., 1989; Curran et al., 1998; Brown et al., 2015).”
BackgroundRole of acetylcholine and serotonin in novelty processing using an oddball paradigm
Caldenhove, S., Borghans, L. G. J. M., Blokland, A., & Sambeth, A. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.05.031 · Cited by 28
Histamine H 1 -receptor blockade in humans affects psychomotor performance but not memory
van Ruitenbeek, P., Vermeeren, A., & Riedel, W. J. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107081526 · Cited by 31
Hogan, J. B., Hodges, D. B., Lelas, S., Gilligan, P. J., McElroy, J. F., & Lindner, M. D. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2028-y · Cited by 27
“Benzodiazepines also produce cognitive deficits that are independent of their sedative and motor effects (Curran and Birch 1991; Hommer et al. 1993; Curran et al. 1998).”
BackgroundHuman genome–guided identification of memory-modulating drugs
Papassotiropoulos, A., Gerhards, C., Heck, A., Ackermann, S., Aerni, A., Schicktanz, N., Auschra, B., Demougin, P., Mumme, E., Elbert, T. R., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314478110 · Cited by 29
Inhibition of MDMA ‐induced increase in cortisol does not prevent acute impairment of verbal memory
Kuypers, K. P. C., de la Torre, R., Farré, M., Pujadas, M., & Ramaekers, J. G. (2013) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02196.x · Cited by 26
“The other pictures were only repeated once in the series(Curran et al., 1998; Van Strien et al., 2007).”
BackgroundDumas, J. A., McDonald, B. C., Saykin, A. J., McAllister, T. W., Hynes, M. L., West, J. D., & NEWHOUSE, P. A. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181e04db9 · Cited by 26
Mental Energy: Assessing the Cognition Dimension
Lieberman, H. R. (2006) · Nutrition Reviews · doi:10.1111/j.1753-4887.2006.tb00252.x · Cited by 27
Cholinergic modulation of sensory perception and plasticity
Kunnath, A. J., Gifford, R. H., & Wallace, M. T. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105323 · Cited by 29
Scaife, J. C., Groves, J., Langley, R. W., Bradshaw, C. M., & Szabadi, E. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881105059343 · Cited by 22
What can modern statistics offer imaging neuroscience?
Lange, N. (2003) · Statistical Methods in Medical Research · doi:10.1191/0962280203sm342ra · Cited by 22
Lorazepam induces an atypical dissociation of visual and auditory event-related potentials
Pompéia, S., Manzano, G. M., Galduróz, J. C. F., Tufik, S., & Bueno, O. F. A. (2003) · Journal of Psychopharmacology · doi:10.1177/0269881103017001690 · Cited by 21
Pompéia, S., Bueno, O. F. A., Lucchesi, L. M., Manzano, G. M., Galduróz, J. C. F., & Tufik, S. (2000) · Journal of Psychopharmacology · doi:10.1177/026988110001400318 · Cited by 20
Dose effects of triazolam on brain activity during episodic memory encoding: a PET study
Mintzer, M. Z., Kuwabara, H., Alexander, M., Brašić, J. R., Ye, W., Ernst, M., Griffiths, R. R., & Wong, D. F. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0446-8 · Cited by 18
“Furthermore, a study by Curran et al. (1998) in which event-related potentials were recorded in participants receiving lorazepam, scopolamine, or diphenhydramine, provided evidence for dissociation of the effects of lorazepam (and scopolamine) on memory and arousal.”
Zhang, J., Ma, L., Li, W., Yang, P., & Qin, L. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.03.006 · Cited by 22
“In human studies, the amplitudes of AEP in oddball paradigm were also found to be decreased after administration of scopolamine (Curran et al., 1998).”
BackgroundBodarky, C. L., Halene, T. B., Ehrlichman, R. S., Banerjee, A., Ray, R., Hahn, C.-G., Jonak, G. J., & Siegel, S. J. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.150938 · Cited by 16
“The NR1neo( / ) mice had significantly larger N40 ERPs than littermate controls.”
BackgroundBehavioural and neural effects of diazepam on a rule-guided response selection task
Muñoz‐Torres, Z., Armony, J. L., Trejo‐Martínez, D., Conde, R., & Corsi‐Cabrera, M. (2011) · Neuroscience Research · doi:10.1016/j.neures.2011.03.009 · Cited by 15
van Ruitenbeek, P., Vermeeren, A., Smulders, F. T. Y., Sambeth, A., & Riedel, W. J. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00103.x · Cited by 17
“In addition, they are known to affect latency and amplitude of several ERP components (Curran et al., 1998; Riba et al., 2005) including P300 (Pompeia et al.”
BackgroundResultInfluentialPTA testing, the westmead post traumatic amnesia scale and opiate analgesia: A cautionary note
McCarter, R., Walton, N., Moore, C., Ward, A. J., & Nelson, I. (2007) · Brain Injury · doi:10.1080/02699050701793793 · Cited by 15
Scaife, J. C., Hou, R. H., Samuels, E. R., Baqui, F., Langley, R. W., Bradshaw, C. M., & Szabadi, E. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106063130 · Cited by 15
Acute neurophysiological effects of the hypnotic zolpidem in healthy volunteers
Lucchesi, L. M., Braga, N. I. D. O., Manzano, G. M., Pompéia, S., & Tufik, S. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.01.013 · Cited by 15
Why an M1 Antagonist Could Be a More Selective Model for Memory Impairment than Scopolamine
Blokland, A., Sambeth, A., Prickaerts, J., & Riedel, W. J. (2016) · Frontiers in Neurology · doi:10.3389/fneur.2016.00167 · Cited by 15
“A subsequent study was able to show a one-sided dissociation between sedation and cognitive impairment (22).”
BackgroundElectroencephalographic Studies of Substance Use and Abuse
Bauer, L. O. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-021-6_4 · Cited by 14
Residual Effects on Memory and Psychomotor Performance of Zaleplon and Other Hypnotic Drugs
O’Hanlon, J. F. (2013) · The Primary Care Companion to The Journal of Clinical Psychiatry · Cited by 12
Warren, C. V., Kroll, C., & Kopp, B. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105221 · Cited by 12
Dissociable effects of histamine H1 antagonists on reaction-time performance in rats
Blokland, A., Scholtissen, B., Vermeeren, A., & Ramaekers, J. G. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00627-x · Cited by 11
van Ruitenbeek, P., Vermeeren, A., & Riedel, W. J. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.12.003 · Cited by 11
Miller, A. M. P., Frick, B. J., Smith, D. M., Radulović, J., & Corcoran, K. A. (2017) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2017.08.010 · Cited by 10
Borghans, L. G. J. M., Sambeth, A., & Blokland, A. (2019) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001157 · Cited by 10
Comparative effects of pharmacotherapy on the maintenance of cognitive function
Allain, H., Schück, S., Mauduit, N., & Djemaï, M. (2001) · European Psychiatry · doi:10.1016/s0924-9338(00)00528-9 · Cited by 10
Antihistamines and driving-related behavior: A review of the evidence for impairment
Moskowitz, H., & Wilkinson, C. J. (2004) · PsycEXTRA Dataset · doi:10.1037/e438302008-001 · Cited by 11
“7 (8-72) Reproduction of completed page authorized”
Shiga, T., Hoshino, H., Ochiai, H., Osakabe, Y., Kanno, K., Horikoshi, S., Miura, I., & Yabe, H. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211035390 · Cited by 11
“, 2004) and P300 (Curran et al., 1998; Watson et al., 2009) are also affected by GABA(A) receptor agonists, there has been no report of the effects of orexin receptor antagonist on MMN and P300.”
BackgroundAnxiolytics in the Treatment of Behavioral and Psychological Symptoms of Dementia
Allain, H., Schück, S., Bentué‐Ferrer, D., Reymann, J., Polard, É., Bourin, M., & Vercelletto, M. (2000) · International Psychogeriatrics · doi:10.1017/s1041610200007158 · Cited by 9
Lange, N., Lake, S. L., Sperling, R. A., Brown, J., Routledge, C. A., Albert, M., & Heckers, S. (2004) · Statistics in Medicine · doi:10.1002/sim.1720 · Cited by 8
Song, Y., Gordon, P. C., Roy, O., Metsomaa, J., Belardinelli, P., Rostami, M., & Ziemann, U. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111167 · Cited by 9
“7), aligning with studies reporting decreased N1 and P2 amplitudes (Caldenhove et al., 2017; Curran et al., 1998).”
Al-Abduljawad, K., Baqui, F., Rw, L., Bradshaw, C. M., & Szabadi, E. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107083843 · Cited by 8
Boeijinga, P. H. (2002) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2002.4.4/pboeijinga · Cited by 4
Chen, C., Martínez, R. M., Chen, Y., Fan, Y., & Cheng, Y. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.991357 · Cited by 4
“It is important to note that RTs may be considered an objective proxy measure for sedation, with the latter being a possible side effect of the GABA receptor agonist lorazepam (Vermeeren et al., 1995; Curran et al., 1998; Mintzer and Griffiths, 2003), and alongside psychomotor performance impairment (Smiley, 1987; Van…”
BackgroundFunctional Imaging of Cognitive Psychopharmacology
(2004) · Elsevier eBooks · doi:10.1016/b978-012264841-0/50018-4 · Cited by 4
Human models as tools in the development of psychotropic drugs
Gilles, C., Schunck, T., Erb, G., Namer, I. J., Hodé, Y., Nédélec, J.-F., Boeijinga, P. H., Luthringer, R., & Macher, J. P. (2002) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2002.4.4/cgilles · Cited by 2
“A dissociation between the cognitive and sedative effects of drugs has also been described.(46) Lorazepam has dose-related memory- and attention-impairing effects.”
BackgroundGevins, A. S., Chan, C. S. Y., Jiang, A., & Sam-Vargas, L. (2012) · Clinical Neurophysiology · doi:10.1016/j.clinph.2012.10.013 · Cited by 2
“Many evoked potential studies, most often employing variants of P300 oddball detection or N100 selective attention tasks, have examined psychoactive drug effects (Callaway and Halliday, 1982; Hammond et al., 1987; Dierks et al., 1994; Semlitsch et al., 1995; Curran et al., 1998; Hermens et al., 2005; Kenemans and Kähk…”
BackgroundEffects of Triazolam on Brain Activity During Episodic Memory Encoding
Mintzer, M. Z., Ernst, M., Griffiths, R. R., Contoreggi, C. S., Kurian, V., Kimes, A. S., & London, E. D. (2000) · PsycEXTRA Dataset · doi:10.1037/e501882009-037 · Cited by 2
GABA Boosts Relief from Coercive Power: an fMRI studyPreprint
Cheng, Y., Martínez, R. M., Chen, Y., Fan, Y., & Chen, C. (2021) · Research Square · doi:10.21203/rs.3.rs-151432/v1 · Cited by 3
“…times have ever been considered as an objective proxy measure for sedation, which can be a side effect accompanying lorazepam's anxiolytic power (Curran et al., 1998; Mintzer and Gri ths, 2003; Vermeeren et al., 1995), thus impairing psychomotor performance and subsequently increasing reaction…”
BackgroundAcute lorazepam administration does not significantly affect moral attitudes or judgments
Martínez, R. M., Wei, L., Fan, Y., Chen, Y., Goh, K. K., Lin, Y.-N., Yang, C.-T., Cheng, Y., & Chen, C. (2025) · Scientific Reports · doi:10.1038/s41598-025-01109-9 · Cited by 1
“One critical aspect of this study was the need to distinguish the effects of lorazepam on moral processing from its potential sedative side effects, given its known impact on psychomotor performance and reaction times (RTs) 37–39 .”
Modern epidemiology of anxiety: results of the Zurich cohort study
Angst, J. (1999) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/(sici)1099-1077(199908)14:1+<s29::aid-hup115>3.0.co;2-7 · Cited by 14
Self-citationKlinkenberg, I. (2012) · Research Publications (Maastricht University) · doi:10.26481/dis.20121213ik · Cited by 1
Anesthesia Meets Memory: Tools for Critical Appraisal
Veselis, R. A. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-322-4_3
van Ruitenbeek, P. (2009) · Research Publications (Maastricht University) · doi:10.26481/dis.20090508pr
Wezenberg, E. (2008) · Radboud Repository (Radboud University)
Can PDE inhibition improve cognition? : Translational insights
Reneerkens, O. A. H. (2013) · Research Publications (Maastricht University) · doi:10.26481/dis.20130418or
Dissociating Allopregnanolone Mnemonic Effec ts from Sedation
Hartman, S. B. (2012) · Digital Commons at Illinois Wesleyan University (Illinois Wesleyan University)
Effects of central nervous system depressant drug overdose on cognitive functions and driving
Dassanayake, W. D. M. T. L. (2012) · Figshare
(2000) · Elsevier eBooks · doi:10.1016/b978-012298190-6/50023-7
Central Cholinergic Nervous System and Its Correlates
(2007) · Springer eBooks · doi:10.1007/978-0-387-46526-5_9
(2004) · Elsevier eBooks · doi:10.1016/b978-012264841-0/50024-x · Cited by 1
Metadata
- Authors
- Curran, H. V., Pooviboonsuk, P., Dalton, J. A., & Lader, M. H.
- Affiliations
- University College London (GB)
- Siriraj Hospital (TH)
- ORCID
- Curran, H. V.
- Venue
- Psychopharmacology
- Published
- 1998-01-08
- Volume
- 135
- Issue
- 1
- Pages
- 27-36
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W1984557730
- Cited by
- 98
- References
- 19
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 3 · 2022: 2 · 2021: 2 · 2019: 1 · 2018: 1 · 2017: 2 · 2016: 3 · 2015: 1 · 2014: 1 · 2013: 5 · 2012: 6
- FWCI
- 3.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Cystic Fibrosis Foundation Therapeutics
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory Processes and Influences
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Cognitive Functions and Memory
- Keywords
- scopolamine, lorazepam, diphenhydramine, arousal, episodic memory, amnesia, anticholinergic agents, benzodiazepines, antihistamines, event-related potentials, word recognition, oddball paradigm, free recall
- MeSH terms
- Adult, Arousal, Diphenhydramine, Double-Blind Method, Electroencephalography, Evoked Potentials, Female, Histamine H1 Antagonists, Humans, Hypnotics and Sedatives, Lorazepam, Male, Memory, Middle Aged, Scopolamine, Muscarinic Antagonists, GABA Modulators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.